An Indispensable Parameters of Streptomycin Include Signs, Symptoms, Mechanism of Action and Adverse Effects
Abstract
The first aminoglycoside antibiotic to be identified was streptomycin, which was first isolated from the bacterium Streptomyces griseus. These days, it is specifically utilized as a component of the multidrug treatment for pulmonary tuberculosis. It is also effective against a number of aerobic gram-negative bacteria. The indications, mode of action, and contraindications of utilizing streptomycin in children and adults will all be covered in this exercise. Additionally, it will explain how streptomycin is administered, dosed, and monitored. Additionally, it will discuss the adverse event profile and other important considerations for the healthcare team while treating aerobic gram-negative infections or pulmonary tuberculosis with streptomycin.
References
Zhu, M., Burman, W. J., Jaresko, G. S., Berning, S. E., Jelliffe, R. W., & Peloquin, C. A. (2001). Population pharmacokinetics of intravenous and intramuscular streptomycin in patients with tuberculosis. Pharmacotherapy, 21(9), 1037–1045.
Daniel, T. M. (2005). Selman Abraham Waksman and the discovery of streptomycin. The International Journal of Tuberculosis and Lung Disease, 9(2), 120–122.
Ball, A. P., Gray, J. A., & Murdoch, J. M. (1975). Antibacterial drugs today: II. Drugs, 10(2), 81–111.
Camba, S. A., Alterthum, F., & De Carvalho Lima, L. P. (1976). Some evidences for the hypothesis of active transport of streptomycin in Pseudomonas aeruginosa. Chemotherapy, 22(6), 341–345.
Mitnick, C. D., McGee, B., & Peloquin, C. A. (2009). Tuberculosis pharmacotherapy: Strategies to optimize patient care. Expert Opinion on Pharmacotherapy, 10(3), 381–401.
Vianna, J. F., Bezerra, K. S., Oliveira, J. N., Albuquerque, E. L., & Fulco, U. L. (2019). Binding energies of the drugs capreomycin and streptomycin in complex with tuberculosis bacterial ribosome subunits. Physical Chemistry Chemical Physics, 21(35), 19192–19200.
Germovsek, E., Barker, C. I., & Sharland, M. (2017). What do I need to know about aminoglycoside antibiotics? Archives of Disease in Childhood: Education and Practice Edition, 102(2), 89–93.
Pla, R. P., Martin, C., Odriozola, J., Armengol, R., & Triginer, J. (1976). [Immuno-allergic hemolytic anemia connected with streptomycin]. Revue Française de Transfusion et Immuno-Hématologie, 19(2), 379–382.
Snider, D. E., Layde, P. M., Johnson, M. W., & Lyle, M. A. (1980). Treatment of tuberculosis during pregnancy. American Review of Respiratory Disease, 122(1), 65–79.
Crofton, J. (2006). The MRC randomized trial of streptomycin and its legacy: A view from the clinical front line. Journal of the Royal Society of Medicine, 99(10), 531–534.
Refbacks
- There are currently no refbacks.